Carl Zeiss Meditec AG (ETR:AFX)
Germany · Delayed Price · Currency is EUR 26.28
+0.26 (1.00%)
May 22, 2026, 5:35 PM CET
Carl Zeiss Meditec AG Cash Flow Statement
Financials in millions EUR. Fiscal year is October - September.
Millions EUR. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Net Income | 95.21 | 142.35 | 180.15 | 292.01 | 295.91 | 237.52 |
Depreciation & Amortization | 143.38 | 126.38 | 132.77 | 74.06 | 69.77 | 61.58 |
Other Adjustments | -8.58 | 0.27 | -39.77 | -8.99 | -51.92 | 0.74 |
Change in Receivables | 23.52 | -106.48 | 21.62 | -21.18 | -74.37 | -62.1 |
Changes in Inventories | -2.15 | 26.6 | 24.38 | -152.6 | -74.63 | 0.02 |
Changes in Accounts Payable | -1.78 | 15.27 | -63.3 | 47.1 | 33.73 | 52.69 |
Changes in Accrued Expenses | 26.6 | 28.2 | -15.73 | -6.73 | 39.27 | 54.46 |
Changes in Income Taxes Payable | -10.1 | -25.38 | -55.87 | 13.45 | -12.87 | 3.62 |
Changes in Other Operating Activities | 10.05 | -17.4 | 56.91 | 26.88 | -33.3 | 6.33 |
Operating Cash Flow | 300.27 | 209.86 | 247.32 | 250.86 | 188.2 | 362.66 |
Operating Cash Flow Growth | 53.51% | -15.15% | -1.41% | 33.30% | -48.11% | 103.14% |
Capital Expenditures | -27.76 | -39.39 | -86.81 | -65.65 | -42.8 | -30.12 |
Sale of Property, Plant & Equipment | 13.72 | 13.69 | 0.07 | 1.02 | 0.48 | 4.83 |
Purchases of Intangible Assets | -35.44 | -37.2 | -65.39 | -48.21 | -39.17 | -35.98 |
Purchases of Investments | -14.84 | -12.37 | -3.9 | -21.59 | -5.85 | -2.42 |
Proceeds from Sale of Investments | - | - | - | 2.42 | 0 | - |
Payments for Business Acquisitions | -3.65 | -2.47 | -1,006 | -10.66 | -61.29 | -11.51 |
Other Investing Activities | -37.95 | -13.28 | 750.02 | 32.36 | 56.01 | -237.65 |
Investing Cash Flow | -119.28 | -91.03 | -412.31 | -110.98 | -92.89 | -75.2 |
Short-Term Debt Issued | 1.48 | 0.07 | 400.21 | -0.01 | -0.6 | 0.42 |
Short-Term Debt Repaid | - | - | - | - | -1.46 | - |
Net Short-Term Debt Issued (Repaid) | 1.48 | 0.07 | 400.21 | -0.01 | -2.05 | 0.42 |
Long-Term Debt Issued | 4.22 | - | - | - | - | - |
Net Long-Term Debt Issued (Repaid) | 4.22 | - | - | - | - | - |
Repurchase of Common Stock | - | 0 | -150.08 | 0 | - | - |
Net Common Stock Issued (Repurchased) | - | 0 | -150.08 | 0 | - | - |
Common Dividends Paid | -48.15 | -52.52 | -98.2 | -98.39 | -80.5 | -44.72 |
Other Financing Activities | -134.86 | -56.37 | 24.32 | -36.7 | -11.69 | -3.94 |
Financing Cash Flow | -180.99 | -108.83 | 176.25 | -135.09 | -94.24 | -285.89 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | -2.65 | -3.02 | -1.58 | -1.92 | -0.78 | -0.34 |
Net Cash Flow | -2.65 | 6.98 | 9.68 | 2.87 | 0.29 | 1.24 |
Free Cash Flow | 272.51 | 170.46 | 160.51 | 185.21 | 145.4 | 332.54 |
Free Cash Flow Growth | 59.86% | 6.21% | -13.34% | 27.38% | -56.28% | 122.88% |
FCF Margin | 12.57% | 7.65% | 7.77% | 8.86% | 7.64% | 20.19% |
Free Cash Flow Per Share | 3.11 | 1.95 | 1.81 | 2.07 | 1.63 | 3.72 |
Levered Free Cash Flow | 238.8 | 255.55 | 571.28 | 226.89 | 271.03 | 385.28 |
Unlevered Free Cash Flow | 248.62 | 278.22 | 137.79 | 182.9 | 270.24 | 410.31 |
Updated May 13, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.